These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36421245)

  • 41. Multicenter Collaborative Study of the Interaction of Antifungal Combinations against
    Meletiadis J; Andes DR; Lockhart SR; Ghannoum MA; Knapp CC; Ostrosky-Zeichner L; Pfaller MA; Chaturvedi V; Walsh TJ
    J Fungi (Basel); 2022 Sep; 8(9):. PubMed ID: 36135692
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Markerless CRISPR-Mediated System for Genome Editing in Candida auris Reveals a Conserved Role for Cas5 in the Caspofungin Response.
    Ennis CL; Hernday AD; Nobile CJ
    Microbiol Spectr; 2021 Dec; 9(3):e0182021. PubMed ID: 34730409
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro synergistic antifungal activities of caspofungin in combination with fluconazole or voriconazole against Candida species determined by the Etest method.
    Yang Q; Liu Z; Wang Y; Xie J; Zhang K; Dong Y; Wang YF
    Int J Infect Dis; 2022 Sep; 122():982-990. PubMed ID: 35907476
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Abrogation of pathogenic attributes in drug resistant Candida auris strains by farnesol.
    Srivastava V; Ahmad A
    PLoS One; 2020; 15(5):e0233102. PubMed ID: 32392266
    [TBL] [Abstract][Full Text] [Related]  

  • 45.
    Romera D; Aguilera-Correa JJ; Gadea I; Viñuela-Sandoval L; García-Rodríguez J; Esteban J
    J Med Microbiol; 2019 Sep; 68(9):1353-1358. PubMed ID: 31271350
    [No Abstract]   [Full Text] [Related]  

  • 46. Evaluation of the Synergistic Activity of Antibacterial and Antifungal Drugs against Candida auris Using an Inkjet Printer-Assisted Method.
    Brennan-Krohn T; Friar L; Ditelberg S; Kirby JE
    Antimicrob Agents Chemother; 2021 Sep; 65(10):e0026821. PubMed ID: 34252295
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro Synergistic Activity of Caspofungin Plus Polymyxin B Against Fluconazole-Resistant Candida glabrata.
    Adams EK; Ashcraft DS; Pankey GA
    Am J Med Sci; 2016 Mar; 351(3):265-70. PubMed ID: 26992255
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Caspofungin Affects Extracellular Vesicle Production and Cargo in
    Amatuzzi RF; Zamith-Miranda D; Munhoz da Rocha IF; Lucena ACR; de Toledo Martins S; Streit R; Staats CC; Trentin G; Almeida F; Rodrigues ML; Nosanchuk JD; Alves LR
    J Fungi (Basel); 2022 Sep; 8(10):. PubMed ID: 36294557
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro activity of anidulafungin, caspofungin, fluconazole and amphotericin B against biofilms and planktonic forms of Candida species isolated from blood culture in patients with hematological malignancies.
    Malchikova A; Klyasova G
    J Mycol Med; 2021 Sep; 31(3):101162. PubMed ID: 34147758
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antifungal activity and killing kinetics of anidulafungin, caspofungin and amphotericin B against Candida auris.
    Dudiuk C; Berrio I; Leonardelli F; Morales-Lopez S; Theill L; Macedo D; Yesid-Rodriguez J; Salcedo S; Marin A; Gamarra S; Garcia-Effron G
    J Antimicrob Chemother; 2019 Aug; 74(8):2295-2302. PubMed ID: 31081031
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Photodynamic Therapy Is Effective Against
    Bapat PS; Nobile CJ
    Front Cell Infect Microbiol; 2021; 11():713092. PubMed ID: 34540717
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification and Antifungal Drug Susceptibility Pattern of
    Deshkar S; Patil N; Amberkar S; Lad A; Siddiqui F; Sharan S
    J Glob Infect Dis; 2022; 14(4):131-135. PubMed ID: 36636301
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Miltefosine as an alternative strategy in the treatment of the emerging fungus Candida auris.
    Barreto TL; Rossato L; de Freitas ALD; Meis JF; Lopes LB; Colombo AL; Ishida K
    Int J Antimicrob Agents; 2020 Aug; 56(2):106049. PubMed ID: 32544569
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Caspofungin and Polymyxin B Reduce the Cell Viability and Total Biomass of Mixed Biofilms of Carbapenem-Resistant
    Fernandes L; Fortes BN; Lincopan N; Ishida K
    Front Microbiol; 2020; 11():573263. PubMed ID: 33391197
    [No Abstract]   [Full Text] [Related]  

  • 55. Transcriptional and translational landscape of
    Zamith-Miranda D; Amatuzzi RF; Munhoz da Rocha IF; Martins ST; Lucena ACR; Vieira AZ; Trentin G; Almeida F; Rodrigues ML; Nakayasu ES; Nosanchuk JD; Alves LR
    Comput Struct Biotechnol J; 2021; 19():5264-5277. PubMed ID: 34630944
    [No Abstract]   [Full Text] [Related]  

  • 56. Echinocandin antifungal drugs in fungal infections: a comparison.
    Chen SC; Slavin MA; Sorrell TC
    Drugs; 2011 Jan; 71(1):11-41. PubMed ID: 21175238
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In Vitro Activity of Berberine Alone and in Combination with Antifungal Drugs Against Planktonic Forms and Biofilms of Trichosporon Asahii.
    Cong L; Liao Y; Yang S; Yang R
    Mycopathologia; 2017 Oct; 182(9-10):829-837. PubMed ID: 28144822
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Candida auris susceptibility on surfaces coated with the antifungal drug caspofungin.
    Lamont-Friedrich SJ; Kidd SE; Giles C; Griesser HJ; Coad BR
    Med Mycol; 2021 Dec; 60(1):. PubMed ID: 34850067
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    Maphanga TG; Naicker SD; Kwenda S; Muñoz JF; van Schalkwyk E; Wadula J; Nana T; Ismail A; Coetzee J; Govind C; Mtshali PS; Mpembe RS; Govender NP;
    Antimicrob Agents Chemother; 2021 Aug; 65(9):e0051721. PubMed ID: 34228535
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    Arendrup MC; Jørgensen KM; Hare RK; Chowdhary A
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.